AA

Adrien Aymery Joel Bresson

Director Director DIN 10859851
DIN 10859851 First appointment Dec 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2024
Shareholding value •••• Premium profile

About Adrien Aymery Joel Bresson

Data last updated:

Adrien Aymery Joel Bresson was a Director at Monolom India Pharma Private Limited (2025–2026) and Additional Director at Vanamali Organics Private Limited (2024–2025). The companies operate in Pharma and Chemicals and Materials.

DIN 10859851
Primary Designation Director
Industry Pharma
First Appointment 11 Dec 2024

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Monolom India Pharma Private Limited U24303PN2017FTC188118
Director22 Jan 20252017₹18.17 Cr (FY 2025)Active
Vanamali Organics Private Limited U24232TG2013PTC086144
Additional Director11 Dec 20242013₹79.39 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Monolom India Pharma Private Limited
Vanamali Organics Private Limited
Premium access

Shareholding and investment profile for Adrien Aymery Joel Bresson

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adrien Aymery Joel Bresson

Adrien Aymery Joel Bresson was first appointed on 11 Dec 2024 as Additional Director at Vanamali Organics Private Limited. The most recent appointment on record is 22 Jan 2025 at Monolom India Pharma Private Limited.

Adrien Aymery Joel Bresson held 2 earlier board appointments: Monolom India Pharma Private Limited (Director, 22 Jan 2025 to 12 Jan 2026); Vanamali Organics Private Limited (Additional Director, 11 Dec 2024 to 30 Jun 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available